Bionanotechnology and the future of glioma.

Abstract

Designer nanoscaled materials have the potential to revolutionize diagnosis and treatment for glioma. This review summarizes current progress in nanoparticle-based therapies for glioma treatment including targeting, drug delivery, gene delivery, and direct tumor ablation. Preclinical and current human clinical trials are discussed. Although progress in the field has been significant over the past decade, many successful strategies demonstrated in the laboratory have yet to be implemented in human clinical trials. Looking forward, we provide examples of combined treatment strategies, which harness the potential for nanoparticles to interact with their biochemical environment, and simultaneously with externally applied photons or magnetic fields. We present our notion of the "ideal" nanoparticle for glioma, a concept that may soon be realized.

• Authors: Peter A Chiarelli, Forrest M Kievit, Miqin Zhang, Richard G Ellenbogen
• Journal: Surgical neurology international (Surg Neurol Int) Vol. 6 Issue Suppl 1 Pg. S45-58 ( 2015) ISSN: 2229-5097 [Print] United States
• PMID: 25722933 (Publication Type: Journal Article)